Works matching AU Choi, I.


Results: 325
    1
    2
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    A PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TUCIDINOSTAT (HBI‐8000) IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY ADULT T‐CELL LEUKEMIA‐LYMPHOMA (ATL)

    Published in:
    Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.122_2880
    By:
    • Izutsu, K.;
    • Utsunomiya, A.;
    • Jo, T.;
    • Yoshida, S.;
    • Ando, K.;
    • Choi, I.;
    • Imaizumi, Y.;
    • Kato, K.;
    • Kurosawa, M.;
    • Kusumoto, S.;
    • Miyagi, T.;
    • Ohtsuka, E.;
    • Sasaki, O.;
    • Shibayama, H.;
    • Shimoda, K.;
    • Takamatsu, Y.;
    • Takano, K.;
    • Tsukasaki, K.;
    • Makita, S.;
    • Yonekura, K.
    Publication type:
    Article
    31

    A PHASE 2B OPEN‐LABEL SINGLE ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF HBI‐8000 (TUCIDINOSTAT) IN PATIENTS WITH RELAPSED OR REFRACTORY PERIPHERAL T‐CELL LYMPHOMA (PTCL)

    Published in:
    Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.121_2880
    By:
    • Kim, W. S.;
    • Rai, S.;
    • Ando, K.;
    • Choi, I.;
    • Izutsu, K.;
    • Tsukamoto, N.;
    • Yokoyama, M.;
    • Tsukasaki, K.;
    • Kuroda, J.;
    • Ando, J.;
    • Hidaka, M.;
    • Koh, Y.;
    • Shibayama, H.;
    • Uchida, T.;
    • Yang, D. H.;
    • Ishitsuka, K.;
    • Ishizawa, K.;
    • Kim, J. S.;
    • Lee, H. G.;
    • Minami, H.
    Publication type:
    Article
    32

    CONSOLIDATION THERAPY USING <sup>90</sup>Y‐IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012).

    Published in:
    Hematological Oncology, 2019, v. 37, p. 392, doi. 10.1002/hon.61_2631
    By:
    • Kanno, M.;
    • Miura, K.;
    • Masaki, Y.;
    • Tsujimura, H.;
    • Iino, M.;
    • Takizawa, J.;
    • Maeda, Y.;
    • Yamamoto, K.;
    • Tamura, S.;
    • Yoshida, A.;
    • Yagi, H.;
    • Yoshida, I.;
    • Kitazume, K.;
    • Masunari, T.;
    • Choi, I.;
    • Kakinoki, Y.;
    • Suzuki, R.;
    • Yoshino, T.;
    • Nakamura, S.;
    • Yoshida, T.
    Publication type:
    Article
    33

    CONSOLIDATION THERAPY USING <sup>90</sup>Y‐IBRITUMOMAB TIUXETAN AFTER BENDAMUSTINE AND RITUXIMAB FOR RELAPSED FOLLICULAR LYMPHOMA; A MULTICENTER, PHASE II STUDY (BRiZ2012).

    Published in:
    Hematological Oncology, 2019, v. 37, p. 392, doi. 10.1002/hon.61_2631
    By:
    • Kanno, M.;
    • Miura, K.;
    • Masaki, Y.;
    • Tsujimura, H.;
    • Iino, M.;
    • Takizawa, J.;
    • Maeda, Y.;
    • Yamamoto, K.;
    • Tamura, S.;
    • Yoshida, A.;
    • Yagi, H.;
    • Yoshida, I.;
    • Kitazume, K.;
    • Masunari, T.;
    • Choi, I.;
    • Kakinoki, Y.;
    • Suzuki, R.;
    • Yoshino, T.;
    • Nakamura, S.;
    • Yoshida, T.
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50